Charles River Laboratories | CRL - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Agilent USD 475M 10M 2026-06
Align Technology USD 410.55M 52.12M 2026-09
Bio-Rad Laboratories USD 212M 400K 2026-06
Bruker USD 238.9M 3.2M 2026-06
Cardinal Health USD 1.62B 115M 2026-06
Charles River Laboratories USD 140.59M 88.31M 2026-09
Cigna USD 3.47B 152M 2026-06
Concord Medical Services Hldg CNY 124.78M 15.58M 2025-12
Danaher USD 2.16B 87M 2026-09
Dentsply International USD 364M 13M 2026-06
Elevance Health USD 10.91B 309M 2025-12
Humana USD 3.36B 614M 2025-03
Illumina USD 281M 8M 2026-09
Incyte USD 364.27M 12.54M 2026-09
Intrexon USD 10.31M 41K 2024-06
IQVIA Holdings USD 569M 5M 2026-09
Laboratory Of America USD 611.4M 34.2M 2026-09
Lakefront Biotherapeutics EUR 22.5M 13M 2026-06
McKesson USD 2.26B 468M 2026-06
Merck EUR 1.57B 49M 2026-06
Mettler Toledo International USD 263.33M 5.01M 2026-06
Novartis USD 3.08B 163M 2026-09
Pfizer USD 3.28B 132M 2026-09
Quest Diagnostics USD 523M 6M 2026-09
Revvity USD 275.33M 3.25M 2026-09
Thermo Fisher Scientific USD 1.86B 46M 2026-09
United Therapeutics USD 206.7M 50.1M 2026-06
UnitedHealth USD 15.22B 1.44B 2025-09
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 398M 7M 2026-09
West Pharmaceutical Services USD 112.9M 4.7M 2026-09